InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NewAmsterdam Pharma Co N.V.

NAMS Clue Score25
Netherlands Fiscal year ends December CIK 0001936258 Results filed 5 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Michael H. Davidson
14 Sep 2026
Chief Executive Officer
Buy
10,000
$22.65
$226.50K
James N Topper
15 Sep 2025
Director
Buy indirect
660
$23.70
$15.64K
James N Topper
8 Sep 2025
Director
Buy indirect
1,260
$24.99
$31.49K
James N Topper
11 Aug 2025
Director
Buy indirect
471
$23.98
$11.29K
James N Topper
25 Jun 2025
Director
Buy indirect
1,260
$18.26
$23.01K
James N Topper
24 Jun 2025
Director
Buy indirect
2,520
$18.43
$46.45K
James N Topper
16 Jun 2025
Director
Buy indirect
8,584
$19.50
$167.38K
James N Topper
26 Mar 2025
Director
Buy indirect
1,135
$22.49
$25.52K
James N Topper
4 Mar 2025
Director
Buy indirect
4,005
$21.02
$84.20K
Juliette Berangere Audet
26 Sep 2024
Chief Business Officer
Buy
1,104
$15.70
$17.33K
Michael H. Davidson
20 Aug 2024
Chief Executive Officer
Buy
5,000
$16.27
$81.35K
Michael H. Davidson
20 Jun 2024
Chief Executive Officer
Buy
5,000
$17.26
$86.31K
James N Topper
26 Mar 2024
Director
Buy indirect
8,429
$21.50
$181.22K
Louis G Lange
13 Feb 2024
Director
Buy indirect
5,000
$19.00
$95.00K
Show all 117 transactions →

What was left out

Form 4 filings counted 109
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 61
Sales at will 12
Transactions with no price 20
Shares from compensation/vesting 4,198,377
History held since 3 Jan 2024